A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Lisa Miller interviewed more than two dozen people about the effects weight-loss drugs have had on their romantic ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity.

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...